Incepta Pharmaceuticals

Incepta introduces Papilovax, vaccine for cervical cancer

The Papilovax vaccine protects against cervical cancer by preventing the HPV virus responsible for cervical cancer.
18 July 2022, 13:29 PM

Detecting cholera in 15 minutes

Scientists at the icddr,b, in partnership with Incepta Pharmaceuticals, have developed a low-cost device which can detect cholera in only 15 minutes.
12 March 2019, 18:00 PM

icddr,b develops law cost rapid diagnostic test kit for cholera

Scientists at the icddr,b, in partnership with Incepta Pharmaceuticals, have developed a locally-made low-cost dipstick device -- Cholkit -- for rapid and effective diagnosis of cholera, generating new hopes of better management the disease.
12 March 2019, 13:55 PM